Labcorp and NACHC Launch Community Health Alliance
BURLINGTON, N.C. and BETHESDA, Md., August 18, 2026 Labcorp and the National Association of Community Health Centers (NACHC) announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BURLINGTON, N.C. and BETHESDA, Md., August 18, 2026 Labcorp and the National Association of Community Health Centers (NACHC) announced...
Austin, Texas and Hoboken, New Jersey, August 17, 2026 Curative and Vytalize Health have finalized a major network agreement...
Abbott Park, Illinois and Bethesda, Maryland, August 17, 2026 Abbott and the National Association of Community Health Centers (NACHC)...
ST. LOUIS, July 29, 2026 C2N Diagnostics, LLC announced that researchers in the United Kingdom are integrating its PrecivityAD2®...
SAN ANTONIO, July 27, 2026 bioAffinity Technologies, Inc. announced the publication of a comprehensive clinical review and white paper...
VANCOUVER, British Columbia, June 2, 2026 Clarius Mobile Health has achieved a significant regulatory milestone with the U.S. Food...
BURLINGTON, N.C. – October 23, 2025 Labcorp (NYSE: LH), a global leader in laboratory diagnostics, announced it will soon...
